These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 1360549)

  • 41. Radioiodinated meta-iodobenzylguanidine uptake in medullary thyroid cancer. A French cooperative study.
    Baulieu JL; Guilloteau D; Delisle MJ; Perdrisot R; Gardet P; Delépine N; Baulieu F; Dupont JL; Talbot JN; Coutris G
    Cancer; 1987 Nov; 60(9):2189-94. PubMed ID: 2894239
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Spectrum of pheochromocytoma in the 131I-MIBG era.
    Cheung PS; Thompson NW; Dmuchowski CF; Sisson JC
    World J Surg; 1988 Aug; 12(4):546-51. PubMed ID: 2901801
    [No Abstract]   [Full Text] [Related]  

  • 43. Pheochromocytoma in multiple endocrine neoplasia type 2A: positive 123I MIBG with negative CT and equivocal 131I MIBG imaging.
    Ishii S; Shishido F; Miyajima M; Sakuma K; Kikuchi K
    Clin Nucl Med; 2012 Jun; 37(6):596-8. PubMed ID: 22614196
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Iodine-131 meta-iodobenzylguanidine (131I-MIBG) for the localization of suspected phaeochromocytoma.
    Warren MJ; Shepstone BJ; Soper N
    Nucl Med Commun; 1989 Jul; 10(7):467-75. PubMed ID: 2797626
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [A case of familial, benign, recurrent and multiple pheochromocytoma whose 131I-MIBG scintigraphy was false negative].
    Shimizu H; Kondo M; Yuzuki Y; Shimono Y; Yagi M; Arai K
    Rinsho Hoshasen; 1989 Sep; 34(9):1055-8. PubMed ID: 2810836
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Diagnostic and therapeutic potential of new radiopharmaceutical agents in medullary thyroid carcinoma.
    Troncone L; Rufini V; De Rosa G; Testa A
    Henry Ford Hosp Med J; 1989; 37(3-4):178-84. PubMed ID: 2576959
    [TBL] [Abstract][Full Text] [Related]  

  • 47. (131I)meta-iodobenzylguanidine scintigraphy and selective venous catheterization after thyroidectomy for medullary thyroid carcinoma.
    Lupoli G; Lombardi G; Panza N; Biondi B; Pacilio G; Lastoria S; Salvatore M
    Med Oncol Tumor Pharmacother; 1991; 8(1):7-13. PubMed ID: 2041383
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Experience with I-131-metaiodobenzylguanidine (MIBG): a retrospective study.
    Chan R; Warshawski RS; Scott J; Arnold RW
    Can Assoc Radiol J; 1987 Mar; 38(1):35-9. PubMed ID: 2884222
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Iodine 131 metaiodobenzylguanidine scintigraphy of medullary carcinoma of the thyroid.
    Skowsky WR; Wilf LH
    South Med J; 1991 May; 84(5):636-41. PubMed ID: 1852077
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Iodine-131 MIBG scintigraphy of neuroendocrine tumors other than pheochromocytoma and neuroblastoma.
    Von Moll L; McEwan AJ; Shapiro B; Sisson JC; Gross MD; Lloyd R; Beals E; Beierwaltes WH; Thompson NW
    J Nucl Med; 1987 Jun; 28(6):979-88. PubMed ID: 3035114
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The diagnostic and therapeutic utility of radioiodinated metaiodobenzylguanidine (MIBG). 5 years of experience.
    Troncone L; Rufini V; Montemaggi P; Danza FM; Lasorella A; Mastrangelo R
    Eur J Nucl Med; 1990; 16(4-6):325-35. PubMed ID: 2351179
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [131I-MIBG scintigraphy in diagnosing pheochromocytoma].
    Huang MJ; Tzen KY; Chen HY; Kao PF
    Taiwan Yi Xue Hui Za Zhi; 1987 Jul; 86(7):781-7. PubMed ID: 3681245
    [No Abstract]   [Full Text] [Related]  

  • 53. Diagnostic localization of extra-adrenal pheochromocytoma: comparison of (123)I-MIBG imaging and (131)I-MIBG imaging.
    Nakatani T; Hayama T; Uchida J; Nakamura K; Takemoto Y; Sugimura K
    Oncol Rep; 2002; 9(6):1225-7. PubMed ID: 12375024
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Nuclear medical therapy of pheochromocytoma].
    Fischer M; Winterberg B; Zidek W; Müller-Rensing R; Vetter H
    Schweiz Med Wochenschr; 1984 Dec; 114(49):1841-3. PubMed ID: 6515381
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Methodology and dosimetry in adrenal medullary imaging with iodine-131 MIBG.
    Lindberg S; Fjälling M; Jacobsson L; Jansson S; Tisell LE
    J Nucl Med; 1988 Oct; 29(10):1638-43. PubMed ID: 2902204
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Diagnosis of pheochromocytoma using [123I]-compared with [131I]-metaiodobenzylguanidine scintigraphy.
    Furuta N; Kiyota H; Yoshigoe F; Hasegawa N; Ohishi Y
    Int J Urol; 1999 Mar; 6(3):119-24. PubMed ID: 10226821
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The clinical use of 131I-meta-iodo-benzylguanidine (MIBG) for the diagnosis of neuroblastoma.
    Zagar I; Mitrović S; Adanja G; Maksimović L; Ivanovski P; Han R; Kovacić K
    Med Pregl; 1993; 46 Suppl 1():74-5. PubMed ID: 8569615
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Detection of medullary thyroid cancer with MIBG imaging for pheochromocytoma.
    Newton TD; Augustine T; Arumugam P; Malik RA
    Clin Nucl Med; 2008 May; 33(5):328-9. PubMed ID: 18431145
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The current status of meta-iodobenzylguanidine and related agents for the diagnosis of neuro-endocrine tumors.
    Shapiro B; Sisson JC; Shulkin BL; Gross MD; Zempel S
    Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):3-8. PubMed ID: 9002740
    [TBL] [Abstract][Full Text] [Related]  

  • 60. 131I-meta-iodobenzylguanidine scintigraphy in patients with neuroblastoma.
    Hibi S; Todo S; Imashuku S; Miyazaki T
    Pediatr Radiol; 1987; 17(4):308-13. PubMed ID: 3601463
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.